Champions Oncology Non-GAAP EPS of $0.01 misses by $0.01, revenue of $14.28M beats by $0.34M
Dec. 13, 2022 4:43 PM ETChampions Oncology, Inc. (CSBR)By: Pranav Ghumatkar, SA News Editor4 Comments
- Champions Oncology press release (NASDAQ:CSBR): Q2 Non-GAAP EPS of $0.01 misses by $0.01.
- Revenue of $14.28M (+21.1% Y/Y) beats by $0.34M.
- Adjusted EBITDA of $686,000
- Discovery targets progressing along the development timeline; expectation to advance to preclinical phase testing in calendar 2023.